Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02645721
Other study ID # 2015/2014-31
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2016
Est. completion date June 2019

Study information

Verified date June 2020
Source Karolinska Institutet
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine whether extensive internet based cognitive behavior treatment program with guidance is a more effective method to treat individuals with alcohol use disorders than a briefer cognitive behavior treatment program without guidance.


Description:

Two Internet based programs based on cognitive behavioral therapy and relapse prevention are evaluated among Internet help seekers, and compared to a waiting list. The design is a three armed randomized controlled trial, and outcomes are measured in terms of changes in alcohol consumption (mean consumption/week, number of heavy drinking days/week), problematic alcohol use, self efficacy, craving, as well as depression, anxiety and quality of life. In addition to this, the following instruments will be used as predictors: ASRS (ADHD), Hp5i (personality assessment). TIC-P, an instrument measuring cost effectiveness will also be used. Treatment Credibility and Adverse Events will also be assessed, the former once during the third week of treatment, and the latter once half way through treatment and once after treatment.

Primary hypothesis is that the more extended program with guidance (group 1) is more effective in reducing mean alcohol consumption and number of heavy drinking days compared to the briefer program with no guidance (group 2), as well as compared to a waiting list (group 3). A responder to treatment is defined as a participant drinking less than 9 (women)/ 14(men) glasses per week and no more than 3 (women)/4 (men) glasses per drinking day during that week.

A minimum of 169 participants will be recruited in two phases: first through an online screening and then through a diagnostic telephone assessment, where SCID will be used to diagnose Alcohol Use Disorders and MINI will be used to diagnose other psychiatric diagnoses. The telephone assessment and all guidance will be conducted by licensed psychologists or master students in psychology under supervision by licensed psychologists.

Included participants will be randomized into three groups:

Group 1: All participants in this group will have access to an extended cognitive behavioral treatment program and have access to a guide with basic training in psychotherapy (CBT) who assists and counsels the participant throughout the program.

Group 2: Participants in this group will have access to a briefer cognitive behavior treatment program with no access to a guide.

Group 3: Participants in this group will be placed on a waiting list for 12 weeks. Thereafter, they will be given access to the same extended cognitive behavior treatment program as Group 1; they will also be offered a possibility to choose between three guidance options: Choice 1: guide with intensive support, Choice 2: guide with support only at request, Choice 3: no guide.

Interim analyses will be undertaken in May 2016 by graduate students in Clinical psychology writing their MSc theses.


Recruitment information / eligibility

Status Completed
Enrollment 166
Est. completion date June 2019
Est. primary completion date June 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- = 18 years

- access to the internet

- consumption of at least 9 (females)/14 (males) glasses of alcohol during the preceding week

- AUDIT = 14 for females, = 16 for men

- have an Alcohol Use Disorder according to the DSM-5 (i.e., at least 2 out of 11 criteria)

Exclusion Criteria:

- insufficient Swedish skills

- reading or writing difficulties, if it is to a degree that it will hamper the treatment

- concurrent other psychological treatment with a content resembling treatments in this study

- severe depression defined as a score of more than 30 on the MADRS-S

- suicide-risk defined as more than 4 points on the MADRS-S question 9, or based on the structured interview

- Drug use problems defined as = 8 p on the DUDIT

- somatic or psychiatric disorders that are contraindicated for the treatment or impairs the ability to receive it (for example schizophrenia, bipolar disease, PTSD)

- has during the last 3 weeks begun medication for alcohol problems or other psychiatric disorder

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Extended self-help program with guidance
See arm description for Experimental
Briefer Self-help program, no guidance
See arm description for Active Comparator
WL: Extended self-help program, choice of guidance intensity
See arm description for Waiting list.

Locations

Country Name City State
Sweden Karolinska Institutet Stockholm

Sponsors (2)

Lead Sponsor Collaborator
Karolinska Institutet Göteborg University

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Time Line Follow Back Number of standard drinks during preceding week (using the Time Line Follow Back) Screening; Changes before treatment, Post-treatment (12 weeks); and changes after 3-, 12-, and 24-months post-treatment
Primary Time Line Follow Back Days of heavy drinking during preceding week (using the Time Line Follow Back) Screening; Changes before treatment, Post-treatment (12 weeks); and changes after 3-, 12-, and 24-months post-treatment
Secondary Alcohol Use Disorders Identification Test assessement of alcohol use problems Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment
Secondary Alcohol Abstinence Self Efficacy Scale instrument measuring self-efficacy Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment
Secondary Penn Alcohol Craving Scale instrument measuring craving for alcohol Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment
Secondary Montgomery Asberg Depression Rating Scale instrument measuring depression Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment
Secondary Euro-QOL 5 D instrument measuring quality of life Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment
Secondary Generalized Anxiety Disorder-7 instrument measuring anxiety Screening, Post-treatment (12 weeks), 3-, 12-, and 24-months post-treatment
Secondary Trimbos and iMTA questionnaire on cCosts associated with Psychiatric illness (TiC-P) Instrument measuring health care consumption and cost-effectiveness (Bouwmans et al., 2013 Screening, 12 months, 24 months post-treatment
Secondary Self-report questionnnaire on satisfaction with internet treatment usability features This instrument contains 40 questions about satisfaction with various features of the internet-based treatment. Results will be analyzed on an aggregated group level. The questionnaire was constructed by the Internet psychiatry clinic in Stockholm. Post-treatment (12 weeks after before-treatment measure)
Secondary Adult ADHD Self Report Scale (ASRS) Screening of ADHD symptoms to be used as predictor of treatment outcome Screening
Secondary Health-relevant Personality traits from a Five-factor perspective (hp5i) Screening of personality traits to be used as predictor of treatment outcome Screening
Secondary Adverse Events Brief questionnaire with questions about any negative side effects of the treatment Halfway through treatment (6 weeks after before-treatment measure) and post-treatment (12 weeks after before-treatment measure)
Secondary Treatment Credibility Scale Brief questionnaire about if the treatment this far is perceived as effective 3 weeks after before-treatment measure
Secondary SCID- section of Alcohol Use Disorders (adjusted to DSM5) Diagnostic interview via telephone, diagnostic criteria of Alcohol Use Disorders (this will be undertaken if resurces allow). This will be a masked assessment, the interviewer will not know which original group the participant was randomized to Screening interview, 12 and 24 months post-treatment
See also
  Status Clinical Trial Phase
Completed NCT02179749 - Mifepristone Treatment of Alcohol Use Disorder Phase 2
Completed NCT02113618 - Effect of Cognitive Training on Alcohol Use Outcomes N/A
Completed NCT01008280 - Baclofen to Reduce Alcohol Use in Veterans With HCV Phase 4
Active, not recruiting NCT02671019 - Effectiveness and Costs of Internet-based Treatment for Harmful Alcohol Use and Face-to-face Treatment in Addiction Care N/A
Completed NCT01751035 - Integrative Risk Reduction and Treatment for Teen Substance Use Problems and PTSD N/A
Active, not recruiting NCT03695653 - Messaging Interventions to Reduce Alcohol Problems Project N/A
Completed NCT02298751 - Exposure Therapy as Aftercare for Alcohol Use Disorder N/A
Terminated NCT01566370 - Zonisamide for Heavy Drinkers With Bipolar Disorder Phase 2
Completed NCT01642381 - Component Analysis for Motivational Interviewing N/A
Completed NCT02511808 - Adaptive Interventions for Problem Drinkers N/A
Completed NCT02384278 - Internet Based Cognitive Behavior Treatment for Alcohol Problems N/A
Completed NCT01613014 - ABT-436 for Alcohol Dependence Phase 2
Completed NCT02905162 - Understanding Longitudinal Clinical Outcomes and Post-release Retention in Care Among HIV-infected Prisoners in Lusaka, Zambia
Completed NCT02808468 - Brief Restructuring Intervention Following Trauma Exposure N/A
Completed NCT01692054 - Risk and Protective Factors of Children and Adolescents Who Were Hospitalized Due to Alcohol Intoxication N/A
Completed NCT02500602 - CAP: Doxazosin in the Treatment of Co-Occurring PTSD and Alcohol Use Disorders Phase 2
Active, not recruiting NCT02713217 - Implementing a Blended Care Model That Integrates Mental Healthcare and Primary Care Using Telemedicine and Care Management for Patients With Depression or Alcohol Use Disorder in Small Primary Care Clinics
Recruiting NCT02465177 - Tailoring Screening, Brief Intervention, and Referral to Treatment for Medical ICU Survivors
Completed NCT02193256 - Varenicline + Prazosin for Heavy Drinking Smokers Early Phase 1
Completed NCT01172210 - Examining Common Substrates of Eating and Alcohol Use Disorders N/A